Conversion of saturated fatty acids to monounsaturated fatty acids by the enzyme stearoyl-Co-A-desaturase (SCD-1) is emerging as a major factor in promoting carcinogenesis including breast cancer ...

GlaxoSmithKline launched new TV spots last week for Lovaza, a prescription omega-3 fish oil capsule indicated for the lowering of very high triglyceride levels. TV spots, as well as the consumer print ...

Prescription fish oil capsules (Lovaza) don’t help atrial fibrillation, study says By Thomas H. Maugh II, Los Angeles Times Nov. 15, 2010 12 AM PT ...

GlaxoSmithKline launched new TV spots last month for Lovaza, a prescription omega-3 fish oil capsule indicated for the lowering of very high triglyceride levels. TV spots, as well as the consumer ...

GlaxoSmithKline’s fish oil tablet Lovaza is not effective for the prevention of atrial fibrillation in certain patients, according to new data. The company has presented data from a 633-patient study ...

Poor Amarin and its still unrealized hopes for its fish oil cholesterol pill, Vascepa. A U.S. appeals court has paved the way for generic versions of blockbuster Lovaza, which GlaxoSmithKline and ...

Teva believes that it was the first to file and the only company to receive approval for generic Lovaza. Thus, the company may enjoy 180 days of marketing exclusivity. The product will be launched ...

Teva plans to commence shipping immediately. Lovaza Capsules, marketed by GlaxoSmithKline (GSK), had annual sales of approximately $1.1B in the United States, according to IMS data as of December ...

Omacor/Lovaza was launched in 2005 in the US and in major European markets, such as France and Spain. IMS Health reports that global end-user sales of the product have increased from US$144 ...

The drugs major says that partner Pronova BioPharma Norge, which owns the patents for Lovaza (omega-3-acid ethyl esters), has entered into an agreement with Canada’s Apotex to settle their patent ...

The success of Lovaza has only whetted the appetite of drug makers. Another prescription heart medication on the market is simply a version of niacin, or vitamin B3.

Lovaza is used to lower triglyceride levels in patients with cardiovascular disease and has annual sales of around $1.1bn in the US, according to IMS data cited by Teva. GSK acquired US rights to ...